Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Direct Comparison of Clinical Characteristics, Outcomes, and Risk Prediction in Patients with COVID-19 and Controls-A Prospective Cohort Study.
Lampart M, Rüegg M, Jauslin AS, Simon NR, Zellweger N, Eken C, Tschudin-Sutter S, Bassetti S, Rentsch KM, Siegemund M, Bingisser R, Nickel CH, Osswald S, Kuster GM, Twerenbold R. Lampart M, et al. Among authors: simon nr. J Clin Med. 2021 Jun 17;10(12):2672. doi: 10.3390/jcm10122672. J Clin Med. 2021. PMID: 34204453 Free PMC article.
Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial.
Barco S, Voci D, Held U, Sebastian T, Bingisser R, Colucci G, Duerschmied D, Frenk A, Gerber B, Götschi A, Konstantinides SV, Mach F, Robert-Ebadi H, Rosemann T, Simon NR, Spechbach H, Spirk D, Stortecky S, Vaisnora L, Righini M, Kucher N; OVID investigators. Barco S, et al. Among authors: simon nr. Lancet Haematol. 2022 Aug;9(8):e585-e593. doi: 10.1016/S2352-3026(22)00175-2. Epub 2022 Jun 30. Lancet Haematol. 2022. PMID: 35779558 Free PMC article. Clinical Trial.
Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial.
Voci D, Götschi A, Held U, Bingisser R, Colucci G, Duerschmied D, Fumagalli RM, Gerber B, Hasse B, Keller DI, Konstantinides SV, Mach F, Rampini SK, Righini M, Robert-Ebadi H, Rosemann T, Roth-Zetzsche S, Sebastian T, Simon NR, Spirk D, Stortecky S, Vaisnora L, Kucher N, Barco S; OVID investigators. Voci D, et al. Among authors: simon nr. Thromb Res. 2023 Jan;221:157-163. doi: 10.1016/j.thromres.2022.10.021. Epub 2022 Nov 12. Thromb Res. 2023. PMID: 36396519 Free PMC article. Clinical Trial.
Diagnoses made in an Emergency Department in rural sub-Saharan Africa.
Mchomvu E, Mbunda G, Simon N, Kitila F, Temba Y, Msumba I, Namamba J, Kilindimo S, Mgubike H, Gingo W, Hatz C, Paris DH, Weisser M, Rohacek M. Mchomvu E, et al. Swiss Med Wkly. 2019 Feb 4;149:w20018. doi: 10.4414/smw.2019.20018. eCollection 2019 Jan 28. Swiss Med Wkly. 2019. PMID: 30715723 Free article.
In vitro modulator responsiveness of 655 CFTR variants found in people with cystic fibrosis.
Bihler H, Sivachenko A, Millen L, Bhatt P, Patel AT, Chin J, Bailey V, Musisi I, LaPan A, Allaire NE, Conte J, Simon NR, Magaret AS, Raraigh KS, Cutting GR, Skach WR, Bridges RJ, Thomas PJ, Mense M. Bihler H, et al. Among authors: simon nr. J Cyst Fibros. 2024 Feb 21:S1569-1993(24)00021-3. doi: 10.1016/j.jcf.2024.02.006. Online ahead of print. J Cyst Fibros. 2024. PMID: 38388235 Free article.
17 results